Evidence map›Paper›PMID 37332492›Full record

ReviewFEMS microbes2022

Anti-malarial plants in Ethiopia and their activities on drug-resistant malaria.

Yimeslal Atnafu Sema, Teshale Areda Waktola

Open access · goldAbstract readReview
In one paragraph

Review in FEMS microbes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yimeslal Atnafu SemaSchool of Biological Sciences and Biotechnolog, Haramaya University, 138 Dire Dawa, Haramaya, Ethiopia.ORCID https://orcid.org/0000-0001-6376-628X
Teshale Areda WaktolaSchool of Biological Sciences and Biotechnolog, Haramaya University, 138 Dire Dawa, Haramaya, Ethiopia.
Haramaya University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Ethiopia, the impacts of malaria continue to cause a many number of morbidity and mortality that accounts to most-outpatient observations. Ethiopia recently designed to attain nationwide malaria control by 2030 by beginning sub-national elimination in districts with low malaria transmission. However, the rise of drug-resistant parasites, especially

Indexed as

anti-malariadrug resistantphytochemical constituentPlasmodium species

Identifiers

PMID37332492
PMCPMC10117797
OpenAlexW4206392589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.